CR3 News Magazine 2018 February: Black History Special Edition - Page 11

CLINICAL TRIALS

African American volunteers are needed to help scientists learn how different treatments affect them. When African Americans take part in clinical trials, they help improve the health of all people and provide greater understanding of health disparities.

were 1 (0.6%) with Lung-RADs 0; 69 (43.1%)

with Lung-RADs 1; 73 (45.6%) Lung-RADs 2; 7(4.3%)

Lung-RADs 3; 10 (6.3%). Of the 6 people undergoing invasive

procedure for biopsy (3 CT guided needle biopsy, 1 transbronchial

needle biopsy, 2 surgical resection) 4 were diagnosed with stage I non-small cell

lung cancer. Three of these underwent surgical resection for treatment, and one

underwent radiation treatment.

Conclusion

Implementation of a multidisciplinary lung cancer screening program enrolling African Americans at high risk of lung cancer led to detection and treatment of lung cancer in 2.5%. Only 10.7% had positive screens (lung-RADs 3 or 4), 3.8% had an invasive biopsy and no one had complications from diagnostic procedures or treatment. Further study is necessary to understand long-term survival benefit of lung cancer screening.

Lung-RADSTM (or lung imaging reporting and data system) is a classification proposed to aid with findings in low dose CT screening exams for lung cancer.

11